Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.
Medscape Medical News
Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.
Medscape Medical News
